Adults 18 to 75 With Type 2 Diabetes: Consider Joining a Weight-Management Study 

Start date
Flexible start date
Therapy area(s)
Diabetes & metabolic health
Location
Phoenix
Compensation
Compensation varies by study
Overweight or Obese
Type 2 Diabetes
Weight loss

Requirements

Participants must meet the following inclusion criteria to be eligible for this clinical trial:

  • Overweight Adults  who also have type 2 diabetes 
  • Ages 18 to 75  
  • Smoking criteria: smokers or non-smokers allowed 
  • BMI:  ≥27kg/m2  
  • Diagnosed with type 2 diabetes 
  • Have an HbA1c ≥7.5% to ≤10.5% at screening 
  • Have had a stable body weight (<5% body weight gain and/or loss) for the 3 months prior to Visit 2 
  • Have been treated with any of the following, alone or in combination, for at least 3 
  • months prior to screening (Visit 1): 
  • diet and exercise 
  • stable dose of metformin (and not more than the locally approved dose), or 
  • SGLT2 inhibitor. 
  • Must not have uncontrolled high blood pressure 
  • Must not have taken GLP-1 inhibitors in the last 6 months. 
  • Must not have had an elevated resting pulse rate (mean >100 bpm) or reduced resting pulse rate (mean <60 bpm) at screening (Visit 1) and baseline (Visit 2). 
  • Must not have any of the cardiovascular conditions within 3 months prior to screening (Visit 1): 
  • acute myocardial infarction 
  • cerebrovascular accident (stroke) 
  • unstable angina, or 
  • Hospitalization due to congestive heart failure. 
  • Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician   
Age: 18-75
Sex: F or M
BMI: 27+
Smoker or non-smoker

About study

The purpose of the study is to test if the two investigational medications, used alone or together, will help reduce weight in adults who have obesity or are overweight and also have type 2 diabetes. The study we are currently enrolling is to find potential treatment options for obesity. Volunteers diagnosed with obesity or who are overweight are needed at this stage of research. This is a research study, and your participation is voluntary. You may stop participating at any time.  Available and willing to commit to study visit structure: 11 outpatient visits.

Submit request for call back.

You can sign up by calling the clinic’s call center or request a call back here.

Locations

Location Start date Status
Phoenix Flexible start date
Enrolling now

What’s the commitment?

0 Overnight

11 Outpatient

Outpatient visits are booked to accommodate assessments in the study schedule. These visits typically last 3–5 hours, but may vary per study.

0 Calls

How do I participate?

Register your interest

Let us know if you’re interested in a clinical trial!

Pre-qualification

We’ll review your medical history and match you with the study that makes sense for you.

Screening

Get all the details about the study, ask any questions you might have, and go through the health screening process (i.e. Labs, Physical Exam)

Enrollment

If you qualify, you’ll be invited to join the study. Once enrolled, you’re officially part of the research!

Want to find out more?

What are the benefits?

Advance potential treatment options

Every clinical research trial is aimed at getting new therapies to those in need. Some may have immediate results for participants while other are helping shape the future landscape of medicine.

No-cost Healthcare

Clinical trials offer a baseline of health assessments at no-cost to study participants. Many studies offer additional assessments and data that are above the standard of care that you would typically receive from your doctor.

Compensation for participation

Many clinical trials offer financial compensation for participation to help cover the cost of associated time, travel and inconvenience.

Improving the lives of yourself and others

Lack of participation in the research phase is a leading cause in delay of effective treatments to the public. No matter the benefit to you, your participation in a clinical trial is key to getting new therapies to the world.